Related references
Note: Only part of the references are listed.Pharmacokinetics and Safety of Single-Dose Tenofovir Disoproxil Fumarate and Emtricitabine in HIV-1-Infected Pregnant Women and Their Infants
Patricia M. Flynn et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Population Pharmacokinetics of Tenofovir in HIV-1-Infected Pregnant Women and Their Neonates (ANRS 12109)
D. Hirt et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
Tenofovir disoproxil fumarate in pregnancy and prevention of mother-to-child transmission of HIV-1: is it time to move on from zidovudine?
C. Foster et al.
HIV MEDICINE (2009)
Steady-state pharmacokinetics of emtricitabine and tenofovir disoproxil fumarate administered alone and in combination in healthy volunteers
M. Robert Blum et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2007)
Estimation of population pharmacokinetic parameters of saquinavir in HIV patients with the MONOLIX software
Marc Lavielle et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2007)
Mechanism of active renal tubular efflux of tenofovir
Adrian S. Ray et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Lack of pharmacokinetic drug interaction between tenofovir disoproxil fumarate and nelfinavir mesylate
M Boffito et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Maximum likelihood estimation in nonlinear mixed effects models
E Kuhn et al.
COMPUTATIONAL STATISTICS & DATA ANALYSIS (2005)
Pregnancy-induced changes in pharmacokinetics - A mechanistic-based approach
GD Anderson
CLINICAL PHARMACOKINETICS (2005)
Determination of tenofovir in human plasma by high-performance liquid chromatography with spectrofluorimetric detection
V Jullien et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2003)
Ways to fit a PK model with some data below the quantification limit
SL Beal
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2001)
Share Paper
